本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Prime Medicine, Inc.

3.32
-0.3250-8.93%
成交量:216.33萬
成交額:728.98萬
市值:5.98億
市盈率:-2.45
高:3.64
開:3.57
低:3.30
收:3.64
52周最高:6.94
52周最低:1.11
股本:1.81億
流通股本:9,979.87萬
量比:1.09
換手率:2.17%
股息:- -
股息率:- -
每股收益(TTM):-1.3521
每股收益(LYR):-1.3521
淨資產收益率:-146.81%
總資產收益率:-40.68%
市淨率:4.95
市盈率(LYR):-2.45

資料載入中...

2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/08

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/10

重要事件披露

8-K/A [Amend] - Current report
2023/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/09

重要事件披露

8-K - Current report
2023/02/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/24

重要事件披露

8-K - Current report
2022/10/20

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/10/19

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/10/17

SEC問詢函

CORRESP [Cover] - Correspondence
2022/10/17

SEC問詢函

CORRESP [Cover] - Correspondence
2022/10/17

SEC問詢函

CORRESP [Cover] - Correspondence
2022/10/17

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/10/17

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses